Sponsor or institution
Clinical trials and research at Shandong Suncadia Medicine Co., Ltd.
As of November 12, 2026, Find a Trial lists 25 clinical trials run by Shandong Suncadia Medicine Co., Ltd. that are recruiting, at sites in 2 countries (most in China (25), Australia (1)). By phase: Phase 2 (9), Phase 1 (5), Phase 3 (5), Phase 1/2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 25Clinical trials
- 2Countries
Newest trials
All recruiting trials (25)
-
HRS-1780 for people with uncontrolled or resistant high blood pressure
This trial tests whether HRS-1780 can safely help adults with uncontrolled or resistant hypertension.
-
HRS-2129 for Acute Gouty Arthritis: Quick Safety and Dosing Check
A Phase 2 trial tests whether HRS-2129 tablets, at different doses, are safe and helpful for people with acute gouty arthritis.
-
Safety test of HRS-7156 in healthy adults
This study tests whether HRS-7156 is safe and tolerated in healthy adults aged 18–55.
-
KRAS G12C pancreatic cancer: a single-arm study of HRS-7058
This study tests whether the KRAS G12C inhibitor HRS-7058 can help adults with advanced pancreatic cancer who have already tried other treatments.
-
Blood pressure medicine HRS-7535 tested in adults with hypertension and overweight/obesity
This study tests whether HRS-7535 lowers blood pressure better than placebo in adults with hypertension who are overweight or obese.
-
HRS-1780 to slow kidney function decline in people with chronic kidney disease
We will test whether daily HRS-1780 tablets can slow kidney function decline compared with placebo in adults with chronic kidney disease who are on standard treatment.
-
HRS-6208 combined with HRS-8080, fulvestrant, or letrozole (± HRS-6209) for advanced metastatic breast cancer
This trial will test HRS-6208 given with HRS-8080, fulvestrant, or letrozole, with or without HRS-6209, in adults with advanced unresectable or metastatic breast cancer to see if the combinations are safe and can help control disease.
-
HRS-2129 for diabetic peripheral neuropathic pain
This trial will test whether HRS-2129 tablets reduce pain in adults with diabetic peripheral neuropathy compared with placebo.
-
HRS-8080 plus dalpiciclib versus fulvestrant plus dalpiciclib for advanced or metastatic breast cancer after adjuvant endocrine therapy resistance
This trial tests whether adding the new drug HRS-8080 to dalpiciclib works better than fulvestrant with dalpiciclib for people with advanced or metastatic breast cancer that became resistant to prior adjuvant hormonal therapy.
-
HRS-8080 versus standard endocrine pills for women with high-risk early breast cancer
This trial tests whether taking HRS-8080 works better than standard endocrine pills (letrozole or tamoxifen) for women with high-risk early breast cancer who have finished 2–5 years of prior endocrine therapy.
-
HRS-1893 for heart failure with preserved ejection fraction
This trial will test whether HRS-1893 is safe and tolerable in adults aged 40 and older who have heart failure with preserved ejection fraction.
-
HRS-7085 tablets for adults with moderate to severe ulcerative colitis
This phase 2 trial will test whether HRS-7085 tablets help adults with moderate to severe ulcerative colitis reduce inflammation and symptoms compared with placebo.
-
HRS-1301 for lowering high cholesterol (dyslipidemia)
This will test whether HRS-1301 can lower LDL cholesterol over 12 weeks in adults with high cholesterol or increased risk of heart disease.
-
HRS-2129 for managing pain after abdominal surgery
This trial will test whether HRS-2129 tablets provide better pain relief than tramadol for adults after abdominal surgery.
-
HRS-7058 with other anti-cancer drugs for adults with solid tumors
This trial will test whether adding HRS-7058 to other anti-cancer drugs is safe and helps shrink tumors in adults with solid tumors.
-
HRS-8080 versus doctor‑chosen treatments for locally advanced or metastatic breast cancer
This trial will test whether the oral drug HRS-8080 works better than treatments chosen by doctors for women with locally advanced or metastatic breast cancer whose disease progressed after prior endocrine therapy.
-
Long-term safety of HRS-1893 for people with hypertrophic cardiomyopathy
This study tests the long-term safety of the oral drug HRS-1893 in people with hypertrophic cardiomyopathy who previously received HRS-1893.
-
Testing HRS-6719 in patients with advanced solid tumors
This study is testing a new treatment called HRS-6719 to see if it can help people with advanced solid tumors that have a specific genetic deficiency feel better and improve their health.
-
Testing HRS-7058 with cancer drugs for advanced tumors
This study is testing a new drug called HRS-7058 combined with other cancer treatments to see if it helps people with advanced tumors feel better and improve their outcomes.
-
Testing HRS-7535 for heart failure and obesity
This study is testing a new medication called HRS-7535 to see if it can help adults with heart failure and obesity feel better.
-
Evaluating the safety and tolerability of HRS-3802 in patients with advanced solid tumors
This study is testing a new drug called HRS-3802 to see if it is safe and tolerable for people with advanced solid tumors who haven't had success with other treatments.
-
Testing HRS-6208 for patients with advanced solid tumors
This study is testing a new treatment called HRS-6208 to see if it is safe and helps people with advanced solid tumors that can't be treated with standard options.
-
Testing new drug combinations for advanced breast cancer
This study is testing different combinations of drugs, including HRS-2189 and Fluvastatin, to see if they can help people with advanced breast cancer feel better and manage their disease.
-
HRS-7058 for adults with advanced malignant tumors
This phase I effort will try different doses of the oral drug HRS-7058 in adults with advanced solid tumors to see if it is safe, how the body processes it, and whether it shows any anti-tumor effect.
-
Combination therapy for advanced breast cancer
This study is testing a new combination of medications to see if it can help women with advanced breast cancer feel better and improve their treatment outcomes.
Quick answers
How many clinical trials run by Shandong Suncadia Medicine Co., Ltd. are recruiting right now?
25, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (25 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 9, Phase 1: 5, Phase 3: 5, Phase 1/2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.